WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq:PPD) has expanded its laboratory test portfolio by adding five new molecular, serology and functional assays designed expressly for COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback